6301 - 6325 of 8801 Results
Title
Year
- Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export2020OPENTitle: Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide exportJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 139Issue #: 6Start Page: 1001End Page: 1024Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-020-02145-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-020-02145-7.pdfCitation Count: 59
-
OPENTitle: Validating Differential Volatilome Profiles in Parkinson’s DiseaseJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 2Start Page: 300End Page: 306Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acscentsci.0c01028Best OA location URL: https://doi.org/10.1021/acscentsci.0c01028Citation Count: 36
-
OPENTitle: Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson’s DiseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 10Start Page: e0162799End Page: e0162799Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0162799Best OA location URL: https://escholarship.org/uc/item/04f2w50wCitation Count: 102
-
OPENTitle: Pathological α-synuclein perturbs nuclear integrityJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 214Issue #:Start Page: 107028End Page: 107028Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107028Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107028Citation Count: 0
-
OPENTitle: The Effect of the COVID-19 Pandemic on People with Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 1365End Page: 1377Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202249Best OA location URL: https://escholarship.org/uc/item/231295zgCitation Count: 165
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers2017OPENTitle: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e0175424End Page: e0175424Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0175424Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175424&type=printableCitation Count: 33
-
OPENTitle: α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controlsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 6Issue #: 12Start Page: 2426End Page: 2436Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.50944Best OA location URL: https://hdl.handle.net/11384/134333Citation Count: 36
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 113
-
OPENTitle: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 2980End Page: 2995Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22822Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/f5e24699-93e4-49fc-a6e3-c3d92fd2d0b9Citation Count: 108
-
RESTRICTEDTitle: The PRIPS study: screening battery for subjects at risk for Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 20Issue #: 1Start Page: 102End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2012.03798.xCitation Count: 119
-
RESTRICTEDTitle: The Progressive Supranuclear Palsy Clinical Deficits Scale accurately reflects functional as well as patient- and caregiver-reported outcomesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108060End Page: 108060Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108060Citation Count: 0
- Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's disease2017RESTRICTEDTitle: Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 101End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.016Citation Count: 20
-
OPENTitle: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00892-7Best OA location URL: https://doi.org/10.1186/s13195-021-00892-7Citation Count: 20
- Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease2018OPENTitle: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 26Issue #: 2Start Page: 246End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13797Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6329649Citation Count: 52
- Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease2021OPENTitle: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1451End Page: 1455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28525Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28525Citation Count: 21
-
RESTRICTEDTitle: Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 124Issue #:Start Page: 130259End Page: 130259Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2025.130259Citation Count: 0
-
OPENTitle: Immunotherapy in Parkinson’s disease: Current status and future directionsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104587End Page: 104587Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104587Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104587Citation Count: 66
-
RESTRICTEDTitle: Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 11Start Page: 1392End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25157Citation Count: 131
-
OPENTitle: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligaseJournal Name: AutophagyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2531025Best OA location URL: https://doi.org/10.1080/15548627.2025.2531025Citation Count: 0
-
RESTRICTEDTitle: Structural connectome alterations in prodromal and de novo Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 45Issue #:Start Page: 21End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.09.019Best OA location URL: http://scholarbank.nus.edu.sg/handle/10635/148986Citation Count: 36
-
RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 34
-
OPENTitle: S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body DementiaJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 14Start Page: 3011End Page: 3024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1508-21.2022Best OA location URL: https://escholarship.org/uc/item/0n57v9mfCitation Count: 39
-
OPENTitle: Synapsin III Regulates Dopaminergic Neuron Development in VertebratesJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 23Start Page: 3902End Page: 3902Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11233902Best OA location URL: https://www.mdpi.com/2073-4409/11/23/3902/pdf?version=1669977075Citation Count: 4
-
OPENTitle: Feedforward activation of PRKN/parkinJournal Name: AutophagyPublisher: Informa UK LimitedVol: 19Issue #: 2Start Page: 729End Page: 730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2022.2100615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9851250Citation Count: 6
-
OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6429430Citation Count: 42